In addition, we constructed APC, p53, Kras mutants to explore key players driving the IFNγ/IFNGR2 axis given that they are common genetic mutations in colorectal cancers influencing CSC dynamics during tumor initiation [6]. This evidence concerns the gene IFNGR2 and neoplasm.